How AI is shortening drug discovery timelines, producing real candidates and reshaping R&D with examples from AlphaFold, Exscientia, BenevolentAI and Insilico.
AI’s Proven Track Record: Accelerating Drug Discovery from Lab to Life Read More »
Concise overview of AI in drug discovery: where it delivers, measurable early-stage gains, and the validation and reproducibility hurdles slowing broader adoption.
AI in Drug Discovery: Progress and Persistent Challenges Read More »
Agentic AI is reshaping drug discovery. Learn why specialized agents outperform general models, how they tackle preclinical toxicology, and how teams can start pilots today.
The Rise of Agentic AI: How Specialized Agents Are Accelerating Drug Discovery Read More »
London startup Perceptic raised $12M to build an AI operating system that unites fragmented pharma R&D workflows, speeding due diligence and clinical translation.
Perceptic’s AI Operating System Raises $12M to Unite Drug Discovery Read More »
QIAGEN and NVIDIA are combining QIAGEN Digital Insights with NVIDIA BioNeMo and graph-based AI to speed target ID, biomarker discovery and drug repurposing.
QIAGEN and NVIDIA Partner to Advance AI Drug Discovery Read More »
Isomorphic Labs raised $2.1 billion to scale its IsoDDE AI drug design engine. Backed by Thrive Capital, Alphabet, Temasek and the UK’s sovereign AI fund, the funding aims to speed therapeutic programs toward clinic.
Isomorphic Labs Secures $2.1B Series B to Accelerate AI Drug Discovery Read More »
How AI is moving from drug discovery into clinical trials, operations and commercial strategy, and why pharma must adopt a holistic, ecosystem view to win.
AI Reshaping Pharma: From Discovery to Strategic Advantage Read More »
Insilico’s AI-discovered Rentosertib (ISM001-055) wins IND for inhalation Phase I in IPF, validating Pharma.AI’s faster, repeatable drug discovery approach.
Rentosertib IND Cleared for Inhalation Study in IPF — AI-Discovered by Insilico Read More »
The Health + AI Insiders Tech Show, hosted by Insiders Intelligence Group, took place yesterday 29 April 2026
at Big Penny Social, London.
That’s a Wrap: The UK’s First Health + AI Tech Show Read More »
Insilico Medicine convenes an industry-first Longevity Board to marry Big Pharma expertise with AI drug discovery, targeting dual-purpose therapies to extend healthspan.
